Related Articles
Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway
miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1
Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease
CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS‑induced lipid peroxidation and inflammation
Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model